Skip to main content
Log in

Risk factors for HIV infection in german i.v. drug abusers

Clinical, serological and epidemiological features

  • Originalien
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

A series of 320 German i.v. drug abusers (32.2% female, 67.8% male) were tested in a cross-sectional study for antibodies against HIV. Seroprevalence increased from 0 in those who discontinued i.v. drug abuse before 1982 to 37.2% in those who stopped injecting drugs in 1985/1986 or who were still addicted. Antibodies to HIV were significantly associated with lymphadenopathy and clinical symptoms (fever, weight loss, diarrhea, fatigue, night sweat, dermal lesions) and with markers of hepatitis A and hepatitis B virus infection.

Participants of the study admitted in 92.5% of cases to “needle sharing” and in 83.1% of cases to sexual contacts among drug abusers. Prostitution and drug abuse in prison were significantly correlated with seropositivity. No antibodies to HIV infection were detected in 131 subjects of a control group of household contacts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

AIDS:

Acquired immunodeficiency syndrome

CDC:

Centers for Disease Control

DVV:

Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten

ESR:

Erythrocyte sedimentation rate

HIV:

Human immunodeficiency virus

References

  1. Angarano G, Pastore G, Monno L, Santantonio T, Luchena N, Schiraldi O (1985) Rapid spread of HTLV-III among drug addicts in Italy. Lancet II:1302

    Google Scholar 

  2. Bienzle U, Guggenmoos-Holzmann I, Zwingenberger K, Thommsen R, Ritter K, Uy A, Bayer H, Schneider J, Hunsmann G, Coester CH, Kalden JR (1985) Lymphadenopathy and antibodies to HTLV-III in homosexual men. Klin Wochenschr 63:597–602

    Google Scholar 

  3. Brettle RP, Davidson J, Davidson SJ, Gray JMN, Inglis JM, Conn JS, Bath GE, Gillon J, McClelland DBL (1986) HTLV-III antibodies in an Edinburgh clinic. Lancet I:1009

    Google Scholar 

  4. Ferroni P, Geroldi D, Galli C, Zanetti AR, Cargnel A (1985) HTLV-III antibody among Italian drug addicts. Lancet II:52–53

    Google Scholar 

  5. Follet EAC, McIntyre A, O'Donnell B, Clements GB, Desselberger U (1986) HTLV-III antibody in drug abusers in the West of Scotland: the Edinburgh connection. Lancet I:446–447

    Google Scholar 

  6. Fuchs D, Blecha HG, Deinhardt F, Dierich MP, Goebel FD, Hengster P, Hinterhuber H, Schoenitzer D, Traill K, Wachter H (1985) High frequency of HTLV-III antibodies among heterosexual IV drug abusers in the Austrian Tyrol. Lancet I:1506

    Google Scholar 

  7. Hunsmann G, Schneider J, Bayer H, Kurth R, Werner A, Brede HD, Erfle V, Mellert W, Brodt HR, Bergmann L, Helm I, Scharrer I, Kreuz W, Berthold H, Wernet P, Schneider EM, Schimpf K, Egli U, Bienzle U, Schmitz H, Kern P, Krüger G, Rasokat H, Lechler E, Seifried E, Hellstern P, Schneider W, Holzer E, Goebel FD, Hehlmann R (1985) Seroepidemiology of HTLV-III (LAV) in the Federal Republic of Germany. Klin Wochenschr 63:233–235

    Google Scholar 

  8. Köhler H, Lange W, Vettermann W, Pauli G, Koch MA (1985) Untersuchung auf LAV/HTLV-III Antikörper bei Insassen Berliner Haftanstalten mit Hepatitis Risiko. Bundesgesundhbl 11:328–329

    Google Scholar 

  9. Lange W, Masihi KN (1986) Durchsuchung mit Hepatitis B Virus bei Drogensüchtigen und Strafgefangenen in Berlin (West). Bundesgesundhbl 29:7–10

    Google Scholar 

  10. Melbye M, Ingerslev J, Biggar RJ, Alexander S, Sarin PS, Goerdert JJ, Zachariae E, Ebbesen P, Stenbjerg S (1985) Intercourse as a possible factor in heterosexual transmission of HTLV-III to spouses of hemophiliacs. N Engl J Med 13:857

    Google Scholar 

  11. Mellenthin K (1985) Drogen und Prostitution. Gynäkologe 7:213–219

    Google Scholar 

  12. Mortimer PP, Vandervelde EM, Jesson WJ, Pereira MS, Burkhardt F (1985) HTLV-III antibody in Swiss and English intravenous drug abusers. Lancet II:449–450

    Google Scholar 

  13. Peutherer JF, Edmond E, Simmonds P, Dickson JD, Bath GE (1985) HTLV-III antibodies in Edinburgh drug addicts. Lancet I:1129–1130

    Google Scholar 

  14. Redfield RR, Markham PD, Salahuddin SZ, Sarngardharan MG, Bodner AJ, Folks TM, Ballou WR, Craig Wright D, Gallo R (1985) Frequent transmission of HTLV-III among spouses of patients with AIDS-related complex and AIDS. JAMA 253:1571–1575

    Google Scholar 

  15. Rodrigo JM, Serra MA, Aguilar E, Del Olmo JA, Gimeno V, Aparisi L (1985) HTLV-III antibodies in drug addicts in Spain. Lancet II:156–157

    Google Scholar 

  16. Update (1986) Acquired immunodeficiency syndrome — United States. MMWR 35:17–21

  17. Update (1986) Acquired immunodeficiency syndrome — Europe. MMWR 35:35–46

  18. Wykoff RF (1985) Female to male transmission of AIDS agent. Lancet II:1017–1018

    Google Scholar 

  19. Zoulek G, Gürtler L, Eberle J, Lorbeer B, Deinhardt F (1986) Zunahme der Prävalenz von Antikörpern gegen LAV/HTLV-III bei Drogenabhängigen in der Bundesrepublik Deutschland. Dtsch Med Wochenschr 15:567–570

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harms, G., Laukamm-Josten, U., Bienzle, U. et al. Risk factors for HIV infection in german i.v. drug abusers. Klin Wochenschr 65, 376–379 (1987). https://doi.org/10.1007/BF01745578

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01745578

Key words

Navigation